← Back to Search

Other

Restrata Graft for Head and Neck Cancers

Phase 2
Waitlist Available
Led By Robert Lindau, MD
Research Sponsored by Nebraska Methodist Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks post operation
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether using a special type of graft along with a skin graft helps adult patients heal better after certain forearm surgeries.

Eligible Conditions
  • Head and Neck Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks post-operation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks post-operation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of surface area
Tendon exposure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: B - Restrata GraftExperimental Treatment1 Intervention
Group II: A - Standard of CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Nebraska Methodist Health SystemLead Sponsor
2 Previous Clinical Trials
750 Total Patients Enrolled
Acera Surgical, Inc.Industry Sponsor
6 Previous Clinical Trials
162 Total Patients Enrolled
Robert Lindau, MDPrincipal InvestigatorNebraska Methodist Hospital
~1 spots leftby Oct 2025